NeueHealth (NYSE:NEUE) - Hisse Senedi Fiyatı, Haberler ve Analizler

NEUE Stoklara Genel Bakış

NEUE temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	1/6
Geçmiş Performans	3/6
Finansal Sağlık	0/6
Temettüler	0/6

Ödüller

Fiyat-Kazanç oranı ( 1.5 x) US piyasasının ( 19.1 x) altındadır

Gelirin yılda 11.08% oranında artması öngörülüyor

Bu yıl karlı hale geldi

Risk Analizi

Negatif hissedar öz sermayesi

Borç işletme nakit akışı tarafından iyi karşılanmıyor

Hissedarlar geçen yıl sulandırıldı

Anlamlı bir piyasa değeri yok ( $41M )

NeueHealth, Inc. Rakipler

Pacific Health Care Organization

OTCPK:PFHO

US$10.5m

Progyny

NasdaqGS:PGNY

US$1.2b

Daxor

NasdaqCM:DXR

US$43.7m

American Shared Hospital Services

NYSEAM:AMS

US$19.4m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti NeueHealth
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	US$5.07
52 Haftanın En Yüksek Seviyesi	US$16.59
52 Haftanın En Düşük Seviyesi	US$4.66
Beta	0.77
11 Aylık Değişim	-8.50%
3 Aylık Değişim	1.00%
1 Yıllık Değişim	-33.09%
33 Yıllık Değişim	-98.43%
5 Yıllık Değişim	n/a
Halka arzdan bu yana değişim	-99.62%

Son Haberler & Güncellemeler

Recent updates

Bright Health narrows footprint to only offer Medicare Advantage in California, Florida

Oct 11

Analysts Have Been Trimming Their Bright Health Group, Inc. (NYSE:BHG) Price Target After Its Latest Report

Aug 13

Bright Health Group Takes Cost Actions To Effect Turnaround

Jul 21

Bright Health Group: Examining A Dumpster Fire

Jan 04

Hissedar Getirileri

	NEUE	US Healthcare	US Pazar
7D	-0.1%	1.0%	0.3%
1Y	-33.1%	2.9%	31.1%

Getiri vs. Endüstri: NEUE geçen yıl % 2.9 oranında getiri sağlayan US Healthcare sektörünün gerisinde kaldı.

Getiri vs Piyasa: NEUE geçen yıl % 31.1 oranında getiri sağlayan US Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is NEUE's price volatile compared to industry and market?
NEUE volatility
NEUE Average Weekly Movement	7.2%
Healthcare Industry Average Movement	7.1%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.8%
10% least volatile stocks in US Market	3.1%

İstikrarlı Hisse Senedi Fiyatı: NEUE son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: NEUE 'nin haftalık oynaklığı geçtiğimiz yıl boyunca 14% dan 7% a düştü.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
2015	1,252	Mike Mikan	www.neuehealth.com

Bir sağlık şirketi olan NeueHealth, Inc. Amerika Birleşik Devletleri'ndeki sağlık tüketicileri, sağlayıcıları ve ödeyicileri için çeşitli sağlık hizmetleri sunmaktadır. İki segment üzerinden faaliyet göstermektedir: NeueCare ve NeueSolutions. NeueCare segmenti, sahip olduğu ve bağlı klinikler aracılığıyla ACA pazarına, medicare ve medicaid'e sağlık hizmetleri sunmaktadır.

NeueHealth, Inc. Temel Bilgiler Özeti

NeueHealth'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
NEUE temel i̇stati̇sti̇kler
Piyasa değeri	US$40.85m
Kazançlar(TTM)	US$27.69m
Gelir(TTM)	US$996.89m

1.5x

F/K Oranı

0.0x

P/S Oranı

NEUE aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
NEUE gelir tablosu (TTM)
Gelir	US$996.89m
Gelir Maliyeti	US$822.11m
Brüt Kâr	US$174.78m
Diğer Giderler	US$147.09m
Kazançlar	US$27.69m

Son Raporlanan Kazançlar

Sep 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	3.36
Brüt Marj	17.53%
Net Kâr Marjı	2.78%
Borç/Özkaynak Oranı	-38.5%

NEUE uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

NEUE Stoklara Genel Bakış

Ödüller

Risk Analizi

NeueHealth, Inc. Rakipler

OTCPK:PFHO

US$10.5m

NasdaqGS:PGNY

US$1.2b

NasdaqCM:DXR

US$43.7m

NYSEAM:AMS

US$19.4m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Third quarter 2024 earnings released: US$6.78 loss per share (vs US$72.52 loss in 3Q 2023)

NeueHealth, Inc. Reaffirms Earnings Guidance for the Year 2024

NeueHealth, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Insufficient new directors

Second quarter 2024 earnings released: US$6.42 loss per share (vs US$8.55 loss in 2Q 2023)

NeueHealth, Inc. Updates Earnings Guidance for the Year 2024

Recent updates

Third quarter 2024 earnings released: US$6.78 loss per share (vs US$72.52 loss in 3Q 2023)

NeueHealth, Inc. Reaffirms Earnings Guidance for the Year 2024

NeueHealth, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Insufficient new directors

Second quarter 2024 earnings released: US$6.42 loss per share (vs US$8.55 loss in 2Q 2023)

NeueHealth, Inc. Updates Earnings Guidance for the Year 2024

NeueHealth, Inc. to Report Q2, 2024 Results on Aug 07, 2024

New major risk - Financial position

NeueHealth, Inc. announced that it has received $150 million in funding

New minor risk - Shareholder dilution

NeueHealth, Inc. Reaffirms Earnings Guidance for the Year 2024

First quarter 2024 earnings released: US$2.31 loss per share (vs US$9.04 loss in 1Q 2023)

NeueHealth, Inc. to Report Q1, 2024 Results on May 08, 2024

NeueHealth, Inc., Annual General Meeting, May 02, 2024

Vice Chairman recently sold US$59k worth of stock

New minor risk - Shareholder dilution

New major risk - Negative shareholders equity

Full year 2023 earnings released: US$70.72 loss per share (vs US$98.28 loss in FY 2022)

NeueHealth, Inc. Provides Earnings Guidance for the Year 2024

NeueHealth, Inc. to Report Q4, 2023 Results on Mar 06, 2024

Third quarter 2023 earnings released: US$72.52 loss per share (vs US$40.11 loss in 3Q 2022)

Bright Health Group, Inc. Provides Earnings Guidance for the Full Year 2023

New major risk - Revenue and earnings growth

Bright Health Group, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Bright Health Group, Inc. Announces Leaving of Jeff Cook as Chief Operating Officer, Effective October 13, 2023

Consensus EPS estimates upgraded to US$51.32 loss

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Bright Health Group, Inc. Revises Its Financial Outlook for 2023

Bright Health Group, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Price target increased by 47% to US$200

Florence Labs, Inc. acquired Zipnosis, Inc. from Bright Health Group, Inc. (NYSE:BHG).

Price target decreased by 14% to US$1.70

Bright Health Group, Inc. Provides Earnings Guidance for the Full Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Bright Health Group Announces Chief Financial Officer Changes

Vice Chairman recently sold US$158k worth of stock

Price target decreased by 24% to US$1.50

Consensus EPS estimates fall by 14%

Full year 2022 earnings released: US$1.23 loss per share (vs US$3.02 loss in FY 2021)

Bright Health Group, Inc. to Report Q4, 2022 Results on Mar 01, 2023

Bright Health Group: Stock Price Has Been Too Heavily Beaten Down

Bright Health Group expects FY23 revenue to be below consensus

Independent Director recently bought US$248k worth of stock

Bright Health Group Receives Continued Listing Standard Notice from NYSE

Bright Health receives non-compliance notice from NYSE

Independent Lead Director recently bought US$294k worth of stock

Price target decreased to US$2.07

High number of new directors

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Bright Health Group, Inc. Reports Goodwill Impairment for the Three Months Ended September 30, 2022

Bright Health Group reports Q3 mixed earnings; revises Fy22 guidance

Bright Health Group, Inc. to Report Q3, 2022 Results on Nov 09, 2022

Bright Health Group, Inc. announced that it has received $175 million in funding from a group of investors

Bright Health Group, Inc. Provides Revenue Guidance for the Year 2023

Bright Health narrows footprint to only offer Medicare Advantage in California, Florida

Analysts Have Been Trimming Their Bright Health Group, Inc. (NYSE:BHG) Price Target After Its Latest Report

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Bright Health Group, Inc. Provides Revenue Guidance for the Full Year 2022

Bright Health Group, Inc. to Report Q2, 2022 Results on Aug 10, 2022